THROUGH THE PROMISE OF BIOLOGY & BIOPSYCHOLOGY.
WHO WE ARE
We are a research organization dedicated to improving early detection, prevention and intervention of trauma-induced illnesses, including post-traumatic stress disorder (PTSD). Our team of experts has made significant strides in this field by identifying a set of biomarkers that can aid in the detection of PTSD and other trauma-induced illnesses.
Through extensive research and analysis, we have identified specific profiles in the immune system that can signal the onset of these conditions, allowing for early intervention and treatment. We are committed to further advancing this research and developing new, innovative ways to improve the lives of those affected by trauma-induced illness.
Committed to Providing the Best Quality
WHAT WE DO
TRAUMA AUTOIMMUNE INDICATOR (TAI) SCREENING
Our team is working to unlock the power of Trauma Autoimmune Indicators (TAIs) for individualized prevention of trauma related diseases and disorders (including PTSD)
A NOVEL APPROACH TO SCREENING FOR TRAUMA AUTOIMMUNE DISEASES
Trauma-induced diseases, including PTSD, affect many lives. PTSD alone affects 7-8% of the general population and as many as 20% of returning combat veterans. The Trauma Autoimmune Indicator (TAI) Screening offers a new and innovative approach to detecting trauma-related health conditions by directly measuring immune response.
HOW WE DO IT
iXpressGenes has conducted preliminary studies of T cell receptor transcriptome sequences that offer an unprecedented analysis of linking an immune repertoire to sensitivity or resilience to PTSD. The T-cell receptor is a protein molecule found on the surface of T cell lymphocytes, a type of white blood cell that forms part of a body’s defense system against pathogens.
PRELIMINARY STUDY RESULTS
An analysis of the immune response from 49 U.S. military veterans shows that there is a clear immune discriminator between those exposed to trauma with positive symptoms of PTS, those exposed to trauma with no symptoms, and those with neither trauma nor symptoms. At the heart of the innovative approach is the analysis of RNA transcriptomes mapped directly back to proteins integral to the immune system.